Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825)
Clinical trial NCT00364286 · COMPLETED
Trial details
- NCT number
- NCT00364286
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2012-11-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.